CMPI’s agenda is research driven. And in turn, our research consists of well-designed clinical outcomes and rigorous econometric studies that analyze the value of new medicines and genomic and molecular-based medical innovation from the consumer’s perspective. We have established three unique research programs that are at the course of our policy and outreach activities.